Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Anticancer activity of mEGP has been reported

May 7, 1998

BE-56980: new antitumor agent discovered by Banyu

May 6, 1998

Apoptosis-inducing iminodiacetic acid derivatives described by Mitsui Toatsu

May 6, 1998

GenVec, Fuso collaborate on cancer gene therapies

May 6, 1998

FDA approves SuperGen's injectable mitomycin

May 6, 1998

New antitumor compounds from Ajinomoto

May 6, 1998

GenVec in-licenses rights to TNF-alpha for gene therapy applications

May 5, 1998

Phase I trial results presented for the antifolate LY-231514

May 5, 1998

Natural antitumor substances with broad-spectrum activity isolated by Banyu scientists

May 5, 1998

Antitumor agents of microbial origin discovered by Nippon Kayaku

May 5, 1998

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...